Fuqu Yu
Impact in
-
- Viral-associated cancers and disorders
-
- Mast cells and histamine
Papers in
- Oncology 7
- Viral-associated cancers and disorders 6
-
- Mast cells and histamine 3
- IL-33, ST2, and ILC Pathways 1
- Co-authors
- Ren Sun (11 shared papers)Chih‐Ming Ho (5 shared papers)Arash Shahangian (1 shared paper)Pak Kin Wong (2 shared papers)Genhong Cheng (1 shared paper)Jiaying Feng (3 shared papers)Sumit K. Chanda (2 shared papers)Josephine N. Harada (2 shared papers)
- Journals
- Archives of Virology (1 paper)Inflammation Research (1 paper)PLoS ONE (1 paper)Journal of Microelectromechanical Systems (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Fuqu Yu
15 papers receiving 702 citations
Peers
Comparison fields: 5 of 90
- Oncology 187
- Immunology 109
- Epidemiology 145
- Immunology and Allergy 25
- Biomedical Engineering 183
Countries citing papers authored by Fuqu Yu
This map shows the geographic impact of Fuqu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuqu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuqu Yu more than expected).
Fields of papers citing papers by Fuqu Yu
This network shows the impact of papers produced by Fuqu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuqu Yu. The network helps show where Fuqu Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fuqu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 144 | |
| 2 | 2007 | 134 | |
| 3 | 2007 | 84 | |
| 4 | 2011 | 72 | |
| 5 | 2007 | 56 | |
| 6 | 2010 | 52 | |
| 7 | 2013 | 50 | |
| 8 | 2004 | 30 | |
| 9 | 2013 | 28 | |
| 10 | 2008 | 22 | |
| 11 | 2010 | 15 | |
| 12 | 2008 | 10 | |
| 13 | 2011 | 10 | |
| 14 | 2008 | 7 | |
| 15 | 2007 | 1 |
About Fuqu Yu
Fuqu Yu is a scholar working on Oncology, Immunology, Molecular Biology, Epidemiology and Physiology, having authored 15 papers that have together received 715 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Cytomegalovirus and herpesvirus research (4 papers), Mast cells and histamine (3 papers), Allergic Rhinitis and Sensitization (2 papers), Herpesvirus Infections and Treatments (2 papers), Asthma and respiratory diseases (2 papers), IL-33, ST2, and ILC Pathways (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Oncology (187 citations), Immunology (109 citations), Epidemiology (145 citations), Immunology and Allergy (25 citations) and Biomedical Engineering (183 citations). Fuqu Yu has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Ren Sun, Chih‐Ming Ho, Arash Shahangian, Pak Kin Wong, Genhong Cheng, Jiaying Feng, Sumit K. Chanda, Josephine N. Harada, Pei‐Yu Chiou and James C. Liao. Their work appears in journals such as Archives of Virology, Inflammation Research, PLoS ONE, Journal of Microelectromechanical Systems and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.